Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study.
Jeon Y, Yang DH, Oh SJ, Park JH, Kim JA, Kim SY, Choi CW, Lee WS, Kim IH, Mun YC, Min GJ, Eom KS, Cho SG. Jeon Y, et al. Among authors: lee ws. Front Oncol. 2023 Mar 28;13:998014. doi: 10.3389/fonc.2023.998014. eCollection 2023. Front Oncol. 2023. PMID: 37056335 Free PMC article.
KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
Kim HJ, Ahn HK, Jung CW, Moon JH, Park CH, Lee KO, Kim SH, Kim YK, Kim HJ, Sohn SK, Kim SH, Lee WS, Kim KH, Mun YC, Kim H, Park J, Min WS, Kim HJ, Kim DH; L/MDS working party, Korean Society of Hematology. Kim HJ, et al. Among authors: lee ko, lee ws. Ann Hematol. 2013 Jan;92(2):163-71. doi: 10.1007/s00277-012-1580-5. Epub 2012 Sep 28. Ann Hematol. 2013. PMID: 23053179
Comparison of therapeutic outcomes between surgical resection followed by R-CHOP and R-CHOP alone for localized primary intestinal diffuse large B-cell lymphoma.
Lee HS, Park LC, Lee EM, Shin SH, Ye BJ, Oh SY, Song MK, Lee SM, Lee WS, Kang BW, Chang MH, Cho SG, Yahng SA, Yoon SS, Kwon JH, Kim YS. Lee HS, et al. Among authors: lee em, lee sm, lee ws. Am J Clin Oncol. 2014 Apr;37(2):182-7. doi: 10.1097/COC.0b013e318271b125. Am J Clin Oncol. 2014. PMID: 23211226 Clinical Trial.
Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia.
Lee SM, Lee WS, Shin HJ, Lee JJ, Sohn SK, Moon JH, Eom HS, Won JH, Lee KH, Lee JH, Kim DY, Yoon SS, Kim I, Jung CW, Kim SJ, Kim H, Lee JH, Ryoo HM, Lee GW, Kim SH, Mun YC, Kim MK, Joo YD; Korean Society of Hematology Adult ALL working party. Lee SM, et al. Among authors: lee kh, lee ws, lee jh, lee jj, lee gw. Ann Hematol. 2013 Aug;92(8):1101-10. doi: 10.1007/s00277-013-1728-y. Epub 2013 Apr 5. Ann Hematol. 2013. PMID: 23558905 Clinical Trial.
Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG.
Kim H, Lee KH, Kim I, Sohn SK, Jung CW, Joo YD, Kim SH, Kim BS, Choi JH, Kwak JY, Kim MK, Bae SH, Shin HJ, Won JH, Lee WS, Oh S, Kim HJ, Park JH; Korean Society of Blood and Marrow Transplantation. Kim H, et al. Among authors: lee kh, lee ws. Leuk Res. 2014 Jul;38(7):730-6. doi: 10.1016/j.leukres.2014.01.002. Epub 2014 Jan 10. Leuk Res. 2014. PMID: 24840870
Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea.
Lee HS, Kim K, Yoon DH, Kim JS, Bang SM, Lee JO, Eom HS, Lee H, Kim I, Lee WS, Bae SH, Kim SH, Lee MH, Do YR, Lee JH, Hong J, Shin HJ, Lee JH, Mun YC, Min CK. Lee HS, et al. Among authors: lee jo, lee h, lee mh, lee ws, lee jh. Biomed Res Int. 2014;2014:253243. doi: 10.1155/2014/253243. Epub 2014 Jun 4. Biomed Res Int. 2014. PMID: 24995279 Free PMC article.
Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients.
Park JS, Lee SE, Jeong SH, Jang EJ, Choi MY, Kim HJ, Kim YK, Kim SH, Zang DY, Oh S, Koo DH, Kim H, Do YR, Kwak JY, Kim JA, Kim DY, Mun YC, Lee WS, Chang MH, Park J, Kwon JH, Kim DW. Park JS, et al. Among authors: lee ws, lee se. Leuk Lymphoma. 2016 Feb;57(2):341-347. doi: 10.3109/10428194.2015.1049166. Epub 2015 Jun 12. Leuk Lymphoma. 2016. PMID: 25947037
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Kim DY, Joo YD, Lim SN, Kim SD, Lee JH, Lee JH, Kim DH, Kim K, Jung CW, Kim I, Yoon SS, Park S, Ahn JS, Yang DH, Lee JJ, Lee HS, Kim YS, Mun YC, Kim H, Park JH, Moon JH, Sohn SK, Lee SM, Lee WS, Kim KH, Won JH, Hyun MS, Park J, Lee JH, Shin HJ, Chung JS, Lee H, Eom HS, Lee GW, Cho YU, Jang S, Park CJ, Chi HS, Lee KH; Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology. Kim DY, et al. Among authors: lee h, lee hs, lee sm, lee kh, lee ws, lee jh, lee jj, lee gw. Blood. 2015 Aug 6;126(6):746-56. doi: 10.1182/blood-2015-03-636548. Epub 2015 Jun 11. Blood. 2015. PMID: 26065651 Free article. Clinical Trial.
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lim SN, Joo YD, Lee KH, Kim DY, Lee JH, Lee JH, Chi HS, Yun SC, Lee WS, Lee SM, Park S, Kim I, Sohn SK, Moon JH, Ryoo HM, Bae SH, Hyun MS, Kim MK, Kim HJ, Yang DH, Eom HS, Lee GW, Jung CW, Won JH, Kim H, Lee JH, Shin HJ, Jang DY. Lim SN, et al. Among authors: lee sm, lee kh, lee ws, lee jh, lee gw. Am J Hematol. 2015 Nov;90(11):1013-20. doi: 10.1002/ajh.24137. Epub 2015 Oct 12. Am J Hematol. 2015. PMID: 26228525 Free article. Clinical Trial.
2,725 results